JP2024525239A5 - - Google Patents
Info
- Publication number
- JP2024525239A5 JP2024525239A5 JP2023563075A JP2023563075A JP2024525239A5 JP 2024525239 A5 JP2024525239 A5 JP 2024525239A5 JP 2023563075 A JP2023563075 A JP 2023563075A JP 2023563075 A JP2023563075 A JP 2023563075A JP 2024525239 A5 JP2024525239 A5 JP 2024525239A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- polyoxyethylene
- castor oil
- cerebral infarction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021070892 | 2021-04-20 | ||
| JP2021070892 | 2021-04-20 | ||
| PCT/US2022/025462 WO2022226013A1 (en) | 2021-04-20 | 2022-04-20 | Pharmaceutical composition comprising the compound smtp-7 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525239A JP2024525239A (ja) | 2024-07-11 |
| JP2024525239A5 true JP2024525239A5 (cg-RX-API-DMAC7.html) | 2025-04-30 |
Family
ID=81648879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563075A Pending JP2024525239A (ja) | 2021-04-20 | 2022-04-20 | 化合物smtp-7を含有する医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240238252A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4326258A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024525239A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230173129A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117279634A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022262593A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023021803A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3214630A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022226013A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240238248A1 (en) * | 2021-05-10 | 2024-07-18 | Ji Xing Pharmaceuticals Hong Kong Limited | Pharmaceutical composition for use in treating cerebral infarction |
| WO2026092761A1 (zh) * | 2024-11-04 | 2026-05-07 | 江苏恒瑞医药股份有限公司 | 包含smtp衍生物的药物组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004224737A (ja) | 2003-01-23 | 2004-08-12 | Ttc:Kk | 新規トリプレニルフェノール化合物 |
| JP4313049B2 (ja) | 2003-01-23 | 2009-08-12 | 株式会社ティーティーシー | 血管新生関連疾患の予防又は治療用医薬組成物 |
| JPWO2007040082A1 (ja) | 2005-10-06 | 2009-04-16 | 国立大学法人東京農工大学 | 腎炎治療又は予防用医薬組成物及びその製造方法 |
| KR20080112184A (ko) | 2006-03-27 | 2008-12-24 | 노우코우다이 티엘오 가부시키가이샤 | 트리프레닐페놀화합물과 트리프레닐페놀화합물의 제조방법,및 혈전용해촉진제 |
| JP2008201688A (ja) * | 2007-02-16 | 2008-09-04 | Tms Co Ltd | 皮膚老化防止剤、化粧料及び皮膚外用剤 |
| JP5605659B2 (ja) * | 2009-07-06 | 2014-10-15 | 国立大学法人東京農工大学 | 細胞保護剤 |
| WO2011125930A1 (ja) | 2010-04-02 | 2011-10-13 | 日本製薬株式会社 | 炎症性腸疾患又は自己免疫性の末梢神経障害の予防又は治療剤 |
| JP7381035B2 (ja) * | 2018-11-02 | 2023-11-15 | 学校法人昭和大学 | Smtp一群又はsmtp-7の製造中間体及びその化学的製造方法 |
| US20240238248A1 (en) * | 2021-05-10 | 2024-07-18 | Ji Xing Pharmaceuticals Hong Kong Limited | Pharmaceutical composition for use in treating cerebral infarction |
-
2022
- 2022-04-20 WO PCT/US2022/025462 patent/WO2022226013A1/en not_active Ceased
- 2022-04-20 BR BR112023021803A patent/BR112023021803A2/pt unknown
- 2022-04-20 JP JP2023563075A patent/JP2024525239A/ja active Pending
- 2022-04-20 AU AU2022262593A patent/AU2022262593A1/en active Pending
- 2022-04-20 CN CN202280033984.6A patent/CN117279634A/zh active Pending
- 2022-04-20 CA CA3214630A patent/CA3214630A1/en active Pending
- 2022-04-20 US US18/287,489 patent/US20240238252A1/en active Pending
- 2022-04-20 KR KR1020237038571A patent/KR20230173129A/ko active Pending
- 2022-04-20 EP EP22723282.4A patent/EP4326258A1/en active Pending